A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma
Clinical trial NCT07392320 · RECRUITING
Trial details
- NCT number
- NCT07392320
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2031-02-10
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.